Positive results for S3 ad push

New research by UTS involving more than 2000 participants has shown S3 advertising is unlikely to lead to inappropriate use of medicine The Australian Self Medication Industry (ASMI) commissioned the Centre for Health Economic Research and Evaluation (CHERE) at the University of Technology Sydney to conduct research into the impact of consumer advertising for S3